Victoria Wang, MD, PhD

Assistant Professor
Division of Hematology/Oncology, UCSF
San Francisco, California, United States

Physician scientist focusing on studying mechanisms of drug resistance to novel therapeutics, early phase clinical trials, and a clinical interest in lung cancer and sarcoma . . . . . . . . . . . . . . . . . . . . . . . . .

Presentation(s):

• Paper 31 - THE TETRAVALENT DEATH RECEPTOR 5 AGONIST OZEKIBART (INBRX-109) IN CHONDROSARCOMA: RESULTS FROM THE RANDOMIZED, REGISTRATIONAL, PHASE 2 CHONDRAGON STUDY

  Friday, November 14, 2025
  8:30 AM - 10:00 AM EST

  Disclosure information not submitted.